TreeWAS – Variant ID: rs11764116

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E10.2 With renal complications	0.000	0.975	0.025
E10.1 With ketoacidosis	0.000	0.976	0.024
E10 Insulin-dependent diabetes mellitus	0.000	0.976	0.024
E10.6 With other specified complications	0.000	0.979	0.021
E10.8 With unspecified complications	0.000	0.980	0.020
E10.0 With coma	0.000	0.980	0.020
E10.4 With neurological complications	0.000	0.982	0.018
E10.7 With multiple complications	0.000	0.983	0.017
E10.5 With peripheral circulatory complications	0.000	0.983	0.017
E10.9 Without complications	0.000	0.983	0.017
E10.3 With ophthalmic complications	0.000	0.988	0.012
F10.3 Withdrawal state	0.000	0.990	0.010
N81.9 Female genital prolapse, unspecified	0.010	0.990	0.000
T84.5 Infection and inflammatory reaction due to internal joint prosthesis	0.000	0.991	0.009
D22.7 Melanocytic naevi of lower limb, including hip	0.000	0.992	0.008
K90.9 Intestinal malabsorption, unspecified	0.008	0.992	0.000
S52.10 Fracture of upper end of radius (closed)	0.000	0.993	0.007
H43.8 Other disorders of vitreous body	0.000	0.993	0.007
G20 Parkinson's disease	0.000	0.994	0.006
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.006	0.994	0.000
H53.0 Amblyopia ex anopsia	0.006	0.994	0.000
Z22.3 Carrier of other specified bacterial diseases	0.000	0.994	0.006
Z22 Carrier of infectious disease	0.000	0.994	0.006
Z29.2 Other prophylactic chemotherapy	0.000	0.994	0.006
Z29 Need for other prophylactic measures	0.000	0.994	0.006
Z29.0 Isolation	0.000	0.995	0.005
K72.9 Hepatic failure, unspecified	0.005	0.995	0.000
Z22.5 Carrier of viral hepatitis	0.000	0.995	0.005
M21.47 Flat foot [pes planus] (acquired)-Ankle/foot	0.005	0.995	0.000
Z29.1 Prophylactic immunotherapy	0.000	0.995	0.005
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.000	0.995	0.005
H53.2 Diplopia	0.005	0.995	0.000
G24.9 Dystonia, unspecified	0.000	0.996	0.004
M53.3 Sacrococcygeal disorders, not elsewhere classified	0.004	0.996	0.000
Z22.1 Carrier of other intestinal infectious diseases	0.000	0.996	0.004
H53 Visual disturbances	0.004	0.996	0.000
Z22.9 Carrier of infectious disease, unspecified	0.000	0.996	0.004
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection	0.000	0.996	0.004
Z22.4 Carrier of infections with a predominantly sexual mode of transmission	0.000	0.996	0.004
Z22.2 Carrier of diphtheria	0.000	0.996	0.004
Z22.0 Carrier of typhoid	0.000	0.996	0.004
Z29.9 Prophylactic measure, unspecified	0.000	0.996	0.004
Z22.8 Carrier of other infectious diseases	0.000	0.996	0.004
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.004	0.996	0.000
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.004	0.996	0.000
Z29.8 Other specified prophylactic measures	0.000	0.996	0.004
S80.8 Other superficial injuries of lower leg	0.004	0.996	0.000
G24 Dystonia	0.000	0.996	0.004
G20-G26 Extrapyramidal and movement disorders	0.000	0.996	0.004
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status	0.000	0.996	0.004
H53.1 Subjective visual disturbances	0.004	0.996	0.000
T42.4 Benzodiazepines	0.000	0.996	0.004
Z28 Immunisation not carried out	0.000	0.996	0.004
Z27 Need for immunisation against combinations of infectious diseases	0.000	0.996	0.004
Z26 Need for immunisation against other single infectious diseases	0.000	0.996	0.004
Z25 Need for immunisation against other single viral diseases	0.000	0.996	0.004
Z23 Need for immunisation against single bacterial diseases	0.000	0.996	0.004
Z20 Contact with and exposure to communicable diseases	0.000	0.996	0.003
H53.4 Visual field defects	0.004	0.996	0.000
Z24 Need for immunisation against certain single viral diseases	0.000	0.996	0.003
M53.39 Sacrococcygeal disorders, not elsewhere classified-Site uns	0.003	0.997	0.000
M53.37 Sacrococcygeal disorders, not elsewhere classified-Lumbosac	0.003	0.997	0.000
M53.36 Sacrococcygeal disorders, not elsewhere classified-Lumbar	0.003	0.997	0.000
M53.35 Sacrococcygeal disorders, not elsewhere classified-Thoracol	0.003	0.997	0.000
M53.34 Sacrococcygeal disorders, not elsewhere classified-Thoracic	0.003	0.997	0.000
M53.33 Sacrococcygeal disorders, not elsewhere classified-Cervicot	0.003	0.997	0.000
M53.32 Sacrococcygeal disorders, not elsewhere classified-Cervical	0.003	0.997	0.000
M53.31 Sacrococcygeal disorders, not elsewhere classified-Occipit-	0.003	0.997	0.000
M53.30 Sacrococcygeal disorders, not elsewhere classified-Mult sit	0.003	0.997	0.000
H53.6 Night blindness	0.003	0.997	0.000
H53.5 Colour vision deficiencies	0.003	0.997	0.000
H53.3 Other disorders of binocular vision	0.003	0.997	0.000
S52.1 Fracture of upper end of radius	0.000	0.997	0.003
D64.9 Anaemia, unspecified	0.000	0.997	0.003
G24.3 Spasmodic torticollis	0.000	0.997	0.003
H43 Disorders of vitreous body	0.000	0.997	0.003
H53.8 Other visual disturbances	0.003	0.997	0.000
Q89.2 Congenital malformations of other endocrine glands	0.003	0.997	0.000
K52.8 Other specified non-infective gastro-enteritis and colitis	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
M53 Other dorsopathies, not elsewhere classified	0.003	0.997	0.000
M53.2 Spinal instabilities	0.003	0.997	0.000
T20.2 Burn of second degree of head and neck	0.003	0.997	0.000
T20 Burn and corrosion of head and neck	0.003	0.997	0.000
A08.4 Viral intestinal infection, unspecified	0.003	0.997	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.003
H43.9 Disorder of vitreous body, unspecified	0.000	0.997	0.003
M21.4 Flat foot [pes planus] (acquired)	0.003	0.997	0.000
T20.0 Burn of unspecified degree of head and neck	0.003	0.997	0.000
M53.22 Spinal instabilities (Cervical region)	0.003	0.997	0.000
G24.8 Other dystonia	0.000	0.997	0.003
G24.4 Idiopathic orofacial dystonia	0.000	0.997	0.003
G24.2 Idiopathic nonfamilial dystonia	0.000	0.997	0.003
G24.1 Idiopathic familial dystonia	0.000	0.997	0.003
G24.0 Drug-induced dystonia	0.000	0.997	0.003
H61.2 Impacted cerumen	0.003	0.997	0.000
T20.3 Burn of third degree of head and neck	0.003	0.997	0.000
M53.9 Dorsopathy, unspecified	0.003	0.997	0.000
S22.40 Multiple fractures of ribs (closed)	0.000	0.997	0.003
G23 Other degenerative diseases of basal ganglia	0.000	0.997	0.003
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.000	0.997	0.003
G22 Parkinsonism in diseases classified elsewhere	0.000	0.997	0.003
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
M53.96 Dorsopathy, unspecified (Lumbar region)	0.003	0.997	0.000
Z23.8 Need for immunisation against other single bacterial diseases	0.000	0.997	0.003
Z23.7 Need for immunisation against pertussis alone	0.000	0.997	0.003
Z23.6 Need for immunisation against diphtheria alone	0.000	0.997	0.003
Z23.5 Need for immunisation against tetanus alone	0.000	0.997	0.003
Z23.4 Need for immunisation against tularaemia	0.000	0.997	0.003
Z23.3 Need for immunisation against plague	0.000	0.997	0.003
Z23.2 Need for immunisation against tuberculosis [BCG]	0.000	0.997	0.003
Z23.1 Need for immunisation against typhoid-paratyphoid alone [TAB]	0.000	0.997	0.003
Z23.0 Need for immunisation against cholera alone	0.000	0.997	0.003
Z25.8 Need for immunisation against other specified single viral diseases	0.000	0.997	0.003
Z25.1 Need for immunisation against influenza	0.000	0.997	0.003
Z25.0 Need for immunisation against mumps alone	0.000	0.997	0.003
Z26.9 Need for immunisation against unspecified infectious disease	0.000	0.997	0.003
Z26.8 Need for immunisation against other specified single infectious diseases	0.000	0.997	0.003
Z26.0 Need for immunisation against leishmaniasis	0.000	0.997	0.003
Z27.9 Need for immunisation against unspecified combinations of infectious diseases	0.000	0.997	0.003
Z27.8 Need for immunisation against other combinations of infectious diseases	0.000	0.997	0.003
Z27.4 Need for immunisation against measles-mumps-rubella [MMR]	0.000	0.997	0.003
Z27.3 Need for immunisation against diphtheria-tetanus-pertussis with poliomyelitis [DTP + polio]	0.000	0.997	0.003
Z27.2 Need for immunisation against diphtheria-tetanus-pertussis with typhoid-paratyphoid [DTP + TAB]	0.000	0.997	0.003
Z27.1 Need for immunisation against diphtheria-tetanus-pertussis, combined [DTP]	0.000	0.997	0.003
Z27.0 Need for immunisation against cholera with typhoid-paratyphoid [cholera + TAB]	0.000	0.997	0.003
Z28.9 Immunisation not carried out for unspecified reason	0.000	0.997	0.003
Z28.8 Immunisation not carried out for other reasons	0.000	0.997	0.003
Z28.2 Immunisation not carried out because of patient's decision for other and unspecified reasons	0.000	0.997	0.003
Z28.1 Immunisation not carried out because of patient's decision for reasons of belief or group pressure	0.000	0.997	0.003
Z28.0 Immunisation not carried out because of contraindication	0.000	0.997	0.003
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.003	0.997	0.000
M06.0 Seronegative rheumatoid arthritis	0.003	0.997	0.000
Z20.9 Contact with and exposure to unspecified communicable disease	0.000	0.997	0.003
Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations	0.000	0.997	0.003
Z20.6 Contact with and exposure to human immunodeficiency virus [HIV]	0.000	0.997	0.003
Z20.5 Contact with and exposure to viral hepatitis	0.000	0.997	0.003
Z20.4 Contact with and exposure to rubella	0.000	0.997	0.003
Z20.3 Contact with and exposure to rabies	0.000	0.997	0.003
Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission	0.000	0.997	0.003
Z20.1 Contact with and exposure to tuberculosis	0.000	0.997	0.003
Z20.0 Contact with and exposure to intestinal infectious diseases	0.000	0.997	0.003
G21 Secondary Parkinsonism	0.000	0.997	0.003
C77.5 Intrapelvic lymph nodes	0.000	0.997	0.003
H43.1 Vitreous haemorrhage	0.000	0.997	0.003
Z24.6 Need for immunisation against viral hepatitis	0.000	0.997	0.003
Z24.4 Need for immunisation against measles alone	0.000	0.997	0.003
Z24.3 Need for immunisation against yellow fever	0.000	0.997	0.003
Z24.2 Need for immunisation against rabies	0.000	0.997	0.003
Z24.1 Need for immunisation against arthropod-borne viral encephalitis	0.000	0.997	0.003
Z24.0 Need for immunisation against poliomyelitis	0.000	0.997	0.003
S52.11 Fracture of upper end of radius (open)	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
M53.27 Spinal instabilities (Lumbosacral region)	0.003	0.997	0.000
H53.9 Visual disturbance, unspecified	0.003	0.997	0.000
Z20.8 Contact with and exposure to other communicable diseases	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
G25.8 Other specified extrapyramidal and movement disorders	0.000	0.997	0.003
Z24.5 Need for immunisation against rubella alone	0.000	0.997	0.002
F10 Mental and behavioural disorders due to use of alcohol	0.000	0.997	0.003
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.000	0.997	0.003
F10.2 Dependence syndrome	0.000	0.997	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
Q89 Other congenital malformations, not elsewhere classified	0.003	0.997	0.000
M06.04 Seronegative rheumatoid arthritis (Hand)	0.003	0.997	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.003	0.997	0.000
H43.0 Vitreous prolapse	0.000	0.997	0.003
T20-T25 Burns and corrosions of external body surface, specified by site	0.003	0.997	0.000
D63.0 Anaemia in neoplastic disease	0.003	0.997	0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.003	0.997	0.000
T42.1 Iminostilbenes	0.000	0.997	0.003
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.003	0.997	0.000
M53.1 Cervicobrachial syndrome	0.002	0.997	0.000
M53.0 Cervicocranial syndrome	0.002	0.997	0.000
G25 Other extrapyramidal and movement disorders	0.000	0.997	0.003
M53.29 Spinal instabilities (Site unspecified)	0.002	0.997	0.000
M53.28 Spinal instabilities (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M53.26 Spinal instabilities (Lumbar region)	0.002	0.997	0.000
M53.25 Spinal instabilities (Thoracolumbar region)	0.002	0.997	0.000
M53.24 Spinal instabilities (Thoracic region)	0.002	0.997	0.000
M53.23 Spinal instabilities (Cervicothoracic region)	0.002	0.997	0.000
M53.21 Spinal instabilities (Occipito-atlanto-axial region)	0.002	0.997	0.000
M53.20 Spinal instabilities (Multiple sites in spine)	0.002	0.997	0.000
F10.9 Unspecified mental and behavioural disorder	0.000	0.997	0.003
T20.7 Corrosion of third degree of head and neck	0.002	0.997	0.000
T20.6 Corrosion of second degree of head and neck	0.002	0.997	0.000
T20.5 Corrosion of first degree of head and neck	0.002	0.997	0.000
T20.4 Corrosion of unspecified degree of head and neck	0.002	0.997	0.000
H43.2 Crystalline deposits in vitreous body	0.000	0.997	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.002
T23.3 Burn of third degree of wrist and hand	0.002	0.997	0.000
T21 Burn and corrosion of trunk	0.002	0.997	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.002	0.997	0.000
M21.49 Flat foot [pes planus] (acquired)-Site unspec	0.002	0.997	0.000
M21.48 Flat foot [pes planus] (acquired)-Other	0.002	0.997	0.000
M21.46 Flat foot [pes planus] (acquired)-Lower leg	0.002	0.997	0.000
M21.45 Flat foot [pes planus] (acquired)-Pelvic/thigh	0.002	0.997	0.000
M21.44 Flat foot [pes planus] (acquired)-Hand	0.002	0.997	0.000
M21.43 Flat foot [pes planus] (acquired)-Forearm	0.002	0.997	0.000
M21.42 Flat foot [pes planus] (acquired)-Upper arm	0.002	0.997	0.000
M21.41 Flat foot [pes planus] (acquired)-Shldr region	0.002	0.997	0.000
M21.40 Flat foot [pes planus] (acquired)-Mult sites	0.002	0.997	0.000
T22.3 Burn of third degree of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
M53.8 Other specified dorsopathies	0.002	0.998	0.000
Q87.4 Marfan's syndrome	0.002	0.998	0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.002	0.998	0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.002	0.998	0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.002	0.998	0.000
M53.99 Dorsopathy, unspecified (Site unspecified)	0.002	0.998	0.000
M53.98 Dorsopathy, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M53.97 Dorsopathy, unspecified (Lumbosacral region)	0.002	0.998	0.000
M53.95 Dorsopathy, unspecified (Thoracolumbar region)	0.002	0.998	0.000
M53.94 Dorsopathy, unspecified (Thoracic region)	0.002	0.998	0.000
M53.93 Dorsopathy, unspecified (Cervicothoracic region)	0.002	0.998	0.000
M53.92 Dorsopathy, unspecified (Cervical region)	0.002	0.998	0.000
M53.91 Dorsopathy, unspecified (Occipito-atlanto-axial region)	0.002	0.998	0.000
M53.90 Dorsopathy, unspecified (Multiple sites in spine)	0.002	0.998	0.000
G23.9 Degenerative disease of basal ganglia, unspecified	0.000	0.998	0.002
G23.8 Other specified degenerative diseases of basal ganglia	0.000	0.998	0.002
G23.3 Multiple system atrophy, cerebellar type	0.000	0.998	0.002
G23.2 Striatonigral degeneration	0.000	0.998	0.002
G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]	0.000	0.998	0.002
G23.0 Hallervorden-Spatz disease	0.000	0.998	0.002
R68.8 Other specified general symptoms and signs	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.000	0.998	0.002
T25 Burn and corrosion of ankle and foot	0.002	0.998	0.000
M23.09 Cystic meniscus (Unspecified ligament or Unspecified meniscus)	0.002	0.998	0.000
A08 Viral and other specified intestinal infections	0.002	0.998	0.000
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.998	0.002
T42.3 Barbiturates	0.000	0.998	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.998	0.002
H50.1 Divergent concomitant strabismus	0.000	0.998	0.002
M06.08 Seronegative rheumatoid arthritis (Other)	0.002	0.998	0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.002	0.998	0.000
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.002	0.998	0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.002	0.998	0.000
G21.9 Secondary Parkinsonism, unspecified	0.000	0.998	0.002
G21.8 Other secondary Parkinsonism	0.000	0.998	0.002
G21.4 Vascular parkinsonism	0.000	0.998	0.002
G21.3 Postencephalitic Parkinsonism	0.000	0.998	0.002
G21.2 Secondary Parkinsonism due to other external agents	0.000	0.998	0.002
G21.0 Malignant neuroleptic syndrome	0.000	0.998	0.002
T21.2 Burn of second degree of trunk	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.998	0.002
M21.57 Acquired clawhand, clubhand, clawfoot and clubfoot (Ankle and foot)	0.002	0.998	0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.002	0.998	0.000
F10.6 Amnesic syndrome	0.000	0.998	0.002
T22.1 Burn of first degree of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.002	0.998	0.000
T23 Burn and corrosion of wrist and hand	0.002	0.998	0.000
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.002	0.998	0.000
A08.3 Other viral enteritis	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
Q80-Q89 Other congenital malformations	0.002	0.998	0.000
A08.1 Acute gastro-enteropathy due to Norwalk agent	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
A08.0 Rotaviral enteritis	0.002	0.998	0.000
F10.8 Other mental and behavioural disorders	0.000	0.998	0.002
F10.7 Residual and late-onset psychotic disorder	0.000	0.998	0.002
F10.4 Withdrawal state with delirium	0.000	0.998	0.002
Q89.9 Congenital malformation, unspecified	0.002	0.998	0.000
Q89.8 Other specified congenital malformations	0.002	0.998	0.000
Q89.7 Multiple congenital malformations, not elsewhere classified	0.002	0.998	0.000
Q89.4 Conjoined twins	0.002	0.998	0.000
Q89.3 Situs inversus	0.002	0.998	0.000
Q89.1 Congenital malformations of adrenal gland	0.002	0.998	0.000
Q89.0 Congenital malformations of spleen	0.002	0.998	0.000
C71.1 Frontal lobe	0.002	0.998	0.000
G21.1 Other drug-induced secondary Parkinsonism	0.000	0.998	0.002
T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
E10-E14 Diabetes mellitus	0.000	0.998	0.002
T25.2 Burn of second degree of ankle and foot	0.002	0.998	0.000
T39.0 Salicylates	0.000	0.998	0.002
G25.9 Extrapyramidal and movement disorder, unspecified	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
T21.1 Burn of first degree of trunk	0.002	0.998	0.000
M53.09 Cervicocranial syndrome-Site unspe	0.002	0.998	0.000
M53.08 Cervicocranial syndrome-Sacral/sacrococ	0.002	0.998	0.000
M53.07 Cervicocranial syndrome-Lumbosacral	0.002	0.998	0.000
M53.06 Cervicocranial syndrome-Lumbar	0.002	0.998	0.000
M53.05 Cervicocranial syndrome-Thoracolumbar	0.002	0.998	0.000
M53.04 Cervicocranial syndrome-Thoracic	0.002	0.998	0.000
M53.03 Cervicocranial syndrome (Cervicothoracic region)	0.002	0.998	0.000
M53.02 Cervicocranial syndrome (Cervical region)	0.002	0.998	0.000
M53.01 Cervicocranial syndrome (Occipito-atlanto-axial region)	0.002	0.998	0.000
M53.00 Cervicocranial syndrome (Multiple sites in spine)	0.002	0.998	0.000
M53.19 Cervicobrachial syndrome-Site unspe	0.002	0.998	0.000
M53.18 Cervicobrachial syndrome-Sacral/sacrococ	0.002	0.998	0.000
M53.17 Cervicobrachial syndrome-Lumbosacral	0.002	0.998	0.000
M53.16 Cervicobrachial syndrome-Lumbar	0.002	0.998	0.000
M53.15 Cervicobrachial syndrome-Thoracolumbar	0.002	0.998	0.000
M53.14 Cervicobrachial syndrome-Thoracic	0.002	0.998	0.000
M53.13 Cervicobrachial syndrome (Cervicothoracic region)	0.002	0.998	0.000
M53.12 Cervicobrachial syndrome (Cervical region)	0.002	0.998	0.000
M53.11 Cervicobrachial syndrome (Occipito-atlanto-axial region)	0.002	0.998	0.000
M53.10 Cervicobrachial syndrome (Multiple sites in spine)	0.002	0.998	0.000
G25.6 Drug-induced tics and other tics of organic origin	0.000	0.998	0.002
G25.4 Drug-induced chorea	0.000	0.998	0.002
G25.1 Drug-induced tremor	0.000	0.998	0.002
R22.3 Localised swelling, mass and lump, upper limb	0.002	0.998	0.000
T22.7 Corrosion of third degree of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
T22.6 Corrosion of second degree of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
T22.5 Corrosion of first degree of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
T22.4 Corrosion of unspecified degree of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
Z83.7 Family history of diseases of the digestive system	0.002	0.998	0.000
M23.03 Cystic meniscus (Medial collateral ligament or Other and unspecified medial meniscus)	0.002	0.998	0.000
G24.5 Blepharospasm	0.000	0.998	0.002
T21.7 Corrosion of third degree of trunk	0.002	0.998	0.000
T21.6 Corrosion of second degree of trunk	0.002	0.998	0.000
T21.5 Corrosion of first degree of trunk	0.002	0.998	0.000
T21.4 Corrosion of unspecified degree of trunk	0.002	0.998	0.000
T21.0 Burn of unspecified degree of trunk	0.002	0.998	0.000
U89.8 Agent resistant to other single specified antibiotic	0.002	0.998	0.000
T21.3 Burn of third degree of trunk	0.002	0.998	0.000
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
H92.1 Otorrhoea	0.000	0.998	0.002
Z89.4 Acquired absence of foot and ankle	0.000	0.998	0.002
M53.89 Other specified dorsopathies (Site unspecified)	0.002	0.998	0.000
M53.88 Other specified dorsopathies (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M53.87 Other specified dorsopathies (Lumbosacral region)	0.002	0.998	0.000
M53.86 Other specified dorsopathies (Lumbar region)	0.002	0.998	0.000
M53.85 Other specified dorsopathies (Thoracolumbar region)	0.002	0.998	0.000
M53.84 Other specified dorsopathies (Thoracic region)	0.002	0.998	0.000
M53.83 Other specified dorsopathies (Cervicothoracic region)	0.002	0.998	0.000
M53.81 Other specified dorsopathies (Occipito-atlanto-axial region)	0.002	0.998	0.000
M53.80 Other specified dorsopathies (Multiple sites in spine)	0.002	0.998	0.000
C77.2 Intra-abdominal lymph nodes	0.000	0.998	0.002
M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot	0.002	0.998	0.000
T36.0 Penicillins	0.000	0.998	0.002
M06.4 Inflammatory polyarthropathy	0.002	0.998	0.000
R68.3 Clubbing of fingers	0.002	0.998	0.000
T25.3 Burn of third degree of ankle and foot	0.002	0.998	0.000
Q83 Congenital malformations of breast	0.002	0.998	0.000
Q82 Other congenital malformations of skin	0.002	0.998	0.000
T25.7 Corrosion of third degree of ankle and foot	0.002	0.998	0.000
T25.6 Corrosion of second degree of ankle and foot	0.002	0.998	0.000
T25.5 Corrosion of first degree of ankle and foot	0.002	0.998	0.000
T25.4 Corrosion of unspecified degree of ankle and foot	0.002	0.998	0.000
T25.1 Burn of first degree of ankle and foot	0.002	0.998	0.000
T25.0 Burn of unspecified degree of ankle and foot	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
A08.5 Other specified intestinal infections	0.002	0.998	0.000
A08.2 Adenoviral enteritis	0.002	0.998	0.000
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.002	0.998	0.000
T24.3 Burn of third degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
G25.2 Other specified forms of tremor	0.000	0.998	0.002
Q82.5 Congenital nonneoplastic naevus	0.002	0.998	0.000
Z89.6 Acquired absence of leg above knee	0.000	0.998	0.002
E13 Other specified diabetes mellitus	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
C77.8 Lymph nodes of multiple regions	0.000	0.998	0.002
R68.0 Hypothermia, not associated with low environmental temperature	0.002	0.998	0.000
T22.0 Burn of unspecified degree of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
F10.5 Psychotic disorder	0.000	0.998	0.002
Q87.8 Other specified congenital malformation syndromes, not elsewhere classified	0.002	0.998	0.000
Q87.5 Other congenital malformation syndromes with other skeletal changes	0.002	0.998	0.000
Q87.3 Congenital malformation syndromes involving early overgrowth	0.002	0.998	0.000
Q87.2 Congenital malformation syndromes predominantly involving limbs	0.002	0.998	0.000
Q87.1 Congenital malformation syndromes predominantly associated with short stature	0.002	0.998	0.000
Q87.0 Congenital malformation syndromes predominantly affecting facial appearance	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
N60.2 Fibroadenosis of breast	0.000	0.998	0.002
T20.1 Burn of first degree of head and neck	0.002	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
M53.82 Other specified dorsopathies (Cervical region)	0.002	0.998	0.000
C77.4 Inguinal and lower limb lymph nodes	0.000	0.998	0.002
M21.8 Other specified acquired deformities of limbs	0.002	0.998	0.000
T23.7 Corrosion of third degree of wrist and hand	0.002	0.998	0.000
T23.6 Corrosion of second degree of wrist and hand	0.002	0.998	0.000
T23.5 Corrosion of first degree of wrist and hand	0.002	0.998	0.000
T23.4 Corrosion of unspecified degree of wrist and hand	0.002	0.998	0.000
T24.7 Corrosion of third degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
T24.6 Corrosion of second degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
T24.5 Corrosion of first degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
T24.4 Corrosion of unspecified degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
T24.1 Burn of first degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
G25.5 Other chorea	0.000	0.998	0.002
Q83.8 Other congenital malformations of breast	0.002	0.998	0.000
T24.2 Burn of second degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
N73.9 Female pelvic inflammatory disease, unspecified	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified	0.002	0.998	0.000
Q84 Other congenital malformations of integument	0.002	0.998	0.000
Q81 Epidermolysis bullosa	0.002	0.998	0.000
Q80 Congenital ichthyosis	0.002	0.998	0.000
R68 Other general symptoms and signs	0.002	0.998	0.000
M21.86 Other specified acquired deformities of limbs (Lower leg)	0.002	0.998	0.000
M23.0 Cystic meniscus	0.002	0.998	0.000
C77.0 Lymph nodes of head, face and neck	0.000	0.998	0.002
T23.1 Burn of first degree of wrist and hand	0.002	0.998	0.000
E12 Malnutrition-related diabetes mellitus	0.000	0.998	0.002
M06.46 Inflammatory polyarthropathy (Lower leg)	0.002	0.998	0.000
F52.2 Failure of genital response	0.000	0.998	0.002
K11.1 Hypertrophy of salivary gland	0.000	0.998	0.002
K25.7 Chronic without haemorrhage or perforation	0.002	0.998	0.000
K72 Hepatic failure, not elsewhere classified	0.002	0.998	0.000
Q85 Phakomatoses, not elsewhere classified	0.002	0.998	0.000
M21.17 Varus deformity, not elsewhere classified (Ankle and foot)	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
E13.9 Without complications	0.000	0.998	0.002
D64 Other anaemias	0.000	0.998	0.002
M21 Other acquired deformities of limbs	0.002	0.998	0.000
N84.2 Polyp of vagina	0.002	0.998	0.000
M21.87 Other specified acquired deformities of limbs (Ankle and foot)	0.002	0.998	0.000
K11.6 Mucocele of salivary gland	0.000	0.998	0.002
M21.83 Other specified acquired deformities of limbs (Forearm)	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
Z90.2 Acquired absence of lung [part of]	0.002	0.998	0.000
K90 Intestinal malabsorption	0.002	0.998	0.000
M06.48 Inflammatory polyarthropathy (Other)	0.002	0.998	0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.002	0.998	0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.002	0.998	0.000
M06.44 Inflammatory polyarthropathy (Hand)	0.002	0.998	0.000
M06.43 Inflammatory polyarthropathy (Forearm)	0.002	0.998	0.000
M06.42 Inflammatory polyarthropathy (Upper arm)	0.002	0.998	0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.002	0.998	0.000
M21.59 Acquired clawhand, clubhand, clawfoot and clubfoot-Site uns	0.002	0.998	0.000
M21.58 Acquired clawhand, clubhand, clawfoot and clubfoot-Other	0.002	0.998	0.000
M21.56 Acquired clawhand, clubhand, clawfoot and clubfoot-Lower le	0.002	0.998	0.000
M21.55 Acquired clawhand, clubhand, clawfoot and clubfoot-Pelvic/t	0.002	0.998	0.000
M21.54 Acquired clawhand, clubhand, clawfoot and clubfoot (Hand)	0.002	0.998	0.000
M21.53 Acquired clawhand, clubhand, clawfoot and clubfoot-Forearm	0.002	0.998	0.000
M21.52 Acquired clawhand, clubhand, clawfoot and clubfoot-Upper ar	0.002	0.998	0.000
M21.51 Acquired clawhand, clubhand, clawfoot and clubfoot-Shldr re	0.002	0.998	0.000
M21.50 Acquired clawhand, clubhand, clawfoot and clubfoot (Multiple sites)	0.002	0.998	0.000
J20.9 Acute bronchitis, unspecified	0.002	0.998	0.000
Q82.9 Congenital malformation of skin, unspecified	0.002	0.998	0.000
Q82.4 Ectodermal dysplasia (anhidrotic)	0.002	0.998	0.000
Q82.3 Incontinentia pigmenti	0.002	0.998	0.000
Q82.2 Mastocytosis	0.002	0.998	0.000
Q82.1 Xeroderma pigmentosum	0.002	0.998	0.000
Q83.9 Congenital malformation of breast, unspecified	0.002	0.998	0.000
Q83.3 Accessory nipple	0.002	0.998	0.000
Q83.2 Absent nipple	0.002	0.998	0.000
Q83.0 Congenital absence of breast with absent nipple	0.002	0.998	0.000
Q85.9 Phakomatosis, unspecified	0.002	0.998	0.000
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.002	0.998	0.000
E55.9 Vitamin D deficiency, unspecified	0.000	0.998	0.002
K50.8 Other Crohn's disease	0.002	0.998	0.000
S49.9 Unspecified injury of shoulder and upper arm	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
Q82.0 Hereditary lymphoedema	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
T78.0 Anaphylactic shock due to adverse food reaction	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.001
E13.8 With unspecified complications	0.000	0.998	0.002
E13.7 With multiple complications	0.000	0.998	0.002
E13.6 With other specified complications	0.000	0.998	0.002
E13.5 With peripheral circulatory complications	0.000	0.998	0.002
E13.4 With neurological complications	0.000	0.998	0.002
E13.3 With ophthalmic complications	0.000	0.998	0.002
E13.2 With renal complications	0.000	0.998	0.002
E13.1 With ketoacidosis	0.000	0.998	0.002
E13.0 With coma	0.000	0.998	0.002
N75.1 Abscess of Bartholin's gland	0.002	0.998	0.000
Q83.1 Accessory breast	0.002	0.998	0.000
R94.4 Abnormal results of kidney function studies	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T80.2 Infections following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
C77.9 Lymph node, unspecified	0.000	0.998	0.002
K90.8 Other intestinal malabsorption	0.002	0.998	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations